Paper189182
Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.
Bergstrand H and 3 others. Mol Pharmacol, 1977. Cited by 108 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Papers, record 189182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/189182
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histamine Antagonists | Major topic |
| Lung | Major topic |
| Phosphodiesterase Inhibitors | Major topic |
| p-Methoxy-N-methylphenethylamine | Major topic |
| 3',5'-Cyclic-AMP Phosphodiesterases | |
| Cyclic GMP | |
| Humans | |
| In Vitro Techniques | |
| Kinetics | |
| Phosphoric Diester Hydrolases |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27,560,192 | Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases. | J Med Chem | 2016 | https://conductscience.org/library/papers/27560192 | PubMed |
| 20,303,168 | The role of cyclic AMP in normalizing the function of engineered human blood microvessels in microfluidic collagen gels. | Biomaterials | 2010 | https://conductscience.org/library/papers/20303168 | PubMed |
| 16,307,683 | Phosphodiesterase 3 inhibition and cough in elderly asthmatics. | Cough | 2005 | https://conductscience.org/library/papers/16307683 | PubMed |
| 7,687,237 | Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response. | Inflammation | 1993 | https://conductscience.org/library/papers/7687237 | PubMed |
| 7,582,471 | Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7582471 | PubMed |
| 6,326,922 | Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6326922 | PubMed |
| 6,270,677 | Cyclic AMP: a mitogenic signal for Swiss 3T3 cells. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6270677 | PubMed |
| 6,168,323 | Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/6168323 | PubMed |
| 2,549,430 | Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart. | Naunyn Schmiedebergs Arch Pharmacol | 1989 | https://conductscience.org/library/papers/2549430 | PubMed |
| 2,542,810 | Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release. | Naunyn Schmiedebergs Arch Pharmacol | 1989 | https://conductscience.org/library/papers/2542810 | PubMed |
| 2,166,956 | Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2166956 | PubMed |
| 2,156,897 | Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2156897 | PubMed |
| 1,846,837 | Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content. | Gut | 1991 | https://conductscience.org/library/papers/1846837 | PubMed |
| 230,069 | Early changes of cyclic nucleotide levels in a mitogenic reaction in the rat mesentery. | Experientia | 1979 | https://conductscience.org/library/papers/230069 | PubMed |
| 217,716 | Effects of [N-(2-oxo-3,5,7-cycloheptatrien-1-yl)] aminooxoacetic acid ethyl ester (AY-25,674) on cyclic 3',5'-nucleotide formation and phosphodiesterase activity. | Experientia | 1979 | https://conductscience.org/library/papers/217716 | PubMed |
| 215,899 | Partial purification and characterization of cyclic nucleotide phosphodiesterases from human bronchial tissue. | Mol Cell Biochem | 1978 | https://conductscience.org/library/papers/215899 | PubMed |
| 208,005 | Possible role of cyclic nucleotides in regulation of noradrenaline release from rat pineal through presynaptic adrenoceptors. | Nature | 1978 | https://conductscience.org/library/papers/208005 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/189182
GET https://conductscience.org/api/papers/v1/189182/authors